Handelsbanken Fonder AB Purchases 3,610 Shares of Humana Inc. $HUM

Handelsbanken Fonder AB boosted its position in Humana Inc. (NYSE:HUM) by 39.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 12,662 shares of the insurance provider’s stock after acquiring an additional 3,610 shares during the quarter. Handelsbanken Fonder AB’s holdings in Humana were worth $3,243,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in the company. Sound View Wealth Advisors Group LLC increased its stake in Humana by 3.5% in the fourth quarter. Sound View Wealth Advisors Group LLC now owns 1,060 shares of the insurance provider’s stock valued at $272,000 after acquiring an additional 36 shares during the last quarter. Unison Advisors LLC increased its stake in Humana by 0.4% in the third quarter. Unison Advisors LLC now owns 10,137 shares of the insurance provider’s stock valued at $2,646,000 after acquiring an additional 37 shares during the last quarter. CoreCap Advisors LLC increased its stake in Humana by 54.4% in the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after acquiring an additional 37 shares during the last quarter. Insigneo Advisory Services LLC increased its stake in Humana by 3.0% in the third quarter. Insigneo Advisory Services LLC now owns 1,484 shares of the insurance provider’s stock valued at $386,000 after acquiring an additional 43 shares during the last quarter. Finally, Columbus Macro LLC increased its stake in Humana by 5.5% in the fourth quarter. Columbus Macro LLC now owns 821 shares of the insurance provider’s stock valued at $210,000 after acquiring an additional 43 shares during the last quarter. 92.38% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on HUM. Weiss Ratings reissued a “sell (d+)” rating on shares of Humana in a research note on Tuesday, April 21st. Zacks Research upgraded shares of Humana from a “strong sell” rating to a “hold” rating in a research report on Wednesday, May 13th. Morgan Stanley raised their target price on shares of Humana from $146.00 to $217.00 and gave the company an “underweight” rating in a research report on Friday, May 15th. Wells Fargo & Company lowered shares of Humana from a “cautious” rating to a “reduce” rating in a research report on Wednesday. Finally, UBS Group raised their target price on shares of Humana from $262.00 to $320.00 and gave the company a “neutral” rating in a research report on Friday. Nine analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and four have given a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $263.35.

Humana Stock Performance

Shares of Humana stock opened at $307.79 on Friday. Humana Inc. has a fifty-two week low of $163.11 and a fifty-two week high of $315.66. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.77 and a quick ratio of 1.77. The firm has a market capitalization of $36.95 billion, a P/E ratio of 32.92, a P/E/G ratio of 2.86 and a beta of 0.68. The company’s 50 day moving average price is $218.13 and its two-hundred day moving average price is $227.64.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. The firm had revenue of $39.65 billion for the quarter, compared to analyst estimates of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. The company’s quarterly revenue was up 23.5% on a year-over-year basis. During the same quarter last year, the business posted $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. On average, equities analysts forecast that Humana Inc. will post 9.01 earnings per share for the current fiscal year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date is Friday, June 26th. Humana’s payout ratio is 37.86%.

Insider Activity at Humana

In other Humana news, insider Sanjay K. Shetty purchased 810 shares of the business’s stock in a transaction dated Monday, February 23rd. The shares were bought at an average price of $185.21 per share, for a total transaction of $150,020.10. Following the completion of the acquisition, the insider owned 11,657 shares in the company, valued at approximately $2,158,992.97. This trade represents a 7.47% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 0.20% of the company’s stock.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.